Yamanouchi/Merck Awarded Attorneys' Fees In Pepcid Patent Challenge

Schein Pharmaceutical's Pepcid patent challenge was ruled "without adequate foundation and speculative at best" by federal court Judge Richard Owen in his Oct. 1 decision to award attorneys' fees to patent holders Yamanouchi and Merck.